October 31, 2024
National Institute on Drug Abuse (NIDA)
The purpose of this Notice is to inform potential applicants of four (4) changes for RFA-DA-25-056 , Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed).
First Change:
The Funding Opportunity Title has been revised.
Currently reads:
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed).
Modified to Read: (changes in bold Italic):
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed).
Second Change:
The application due date and NOFO expiration date have been extended to December 6 and 7, 2024, respectively.
In Part 1. Overview Information, Key Dates, the following section has been changed:
Currently reads:
Application Due Dates |
Review and Award Cycles |
||||
---|---|---|---|---|---|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS - New/Renewal/Resubmission/Revision, as allowed |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
November 13, 2024 | Not Applicable | Not Applicable | March 2025 | May 2025 | July 2025 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this Notice of Funding Opportunity (NOFO).
Expiration Date
November 14, 2024
Modified to Read: (changes in bold Italic)
Application Due Dates |
Review and Award Cycles |
||||
---|---|---|---|---|---|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS - New/Renewal/Resubmission/Revision, as allowed |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
December 6, 2024 | Not Applicable | Not Applicable | March 2025 | May 2025 | July 2025 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this Notice of Funding Opportunity (NOFO).
Expiration Date
December 7, 2024
Third change:
In Section IV. Application and Submission Information, Content and Form of Application Submission, the following has been changed:
Currently reads:
Component | Component Type for Submission | Page Limit | Required/Optional | Minimum | Maximum |
---|---|---|---|---|---|
Overall | Overall | 12 | Required | 1 | 1 |
Outreach and Networking | Project | 6 | Required | 1 | 1 |
Drug Development Training and Education | Project | 6 | Required | 1 | 1 |
Subproject Management | Project | 6 | Required | 1 | 1 |
Modified to Read: (changes in bold Italic)
Component | Component Type for Submission |
Research Strategy/ Program Plan Page Limit |
Required/ Optional |
Minimum | Maximum |
---|---|---|---|---|---|
Overall | Overall | 12 | Required | 1 | 1 |
Administrative Core | Admin Core | 6 | Required | 1 | 1 |
Outreach and Networking | Core | 6 | Required | 1 | 1 |
Drug Development Training and Education | Core | 6 | Required | 1 | 1 |
Subproject Management | Project | 12 | Required | 1 | No Maximum |
In Section IV. Application and Submission Information, Budget (Overall), the following section has been changed:
Currently reads:
The total direct cost for the Center should not exceed $1.9 million per year. The direct cost for individual subawards should not exceed $200,000 and varies depending on the specific experiments.
Component Type for Submission | Budget |
---|---|
Overall (Administrative) | $100,000 |
Outreach and Networking | $100,000 |
Drug Development Training and Education | $300,000 |
Subproject Management | $1,400,000 |
Modified to Read: (changes in bold Italic)
The total direct cost for the Center should not exceed $1.9 million per year. The direct cost for individual subawards should not exceed $200,000 and varies depending on the specific experiments. Suggested Budget Caps (Direct costs only) listed below:
Component Type for Submission | Budget |
---|---|
Administrative Core | $100,000 |
Outreach and Networking | $100,000 |
Drug Development Training and Education | $300,000 |
Subproject Management | $1,400,000 |
Fourth change:
In PHS 398 Research Plan (Administrative Core), the following are instructions for the Admin Core.
Specific Aims: State the specific aims for the Administrative Core and provide a rationale and description of how each aim enhances the operation of the Center. In addition, state the cores relationship to the proposed Centers goals and how it is related to the other Components of the Center in the application.
Research Strategy: Applicants must explain the plans for organizational and administrative management for the Center overall, for coordination and communication within the Center, and for coordination and communication with NIDA. Applicants must explain the project management oversight process and describe a plan for tracking progress for all aspects of the component projects and include a description of any platforms or software used to track Center progress. Plans for ensuring compliance with all applicable NIH guidelines and policies and monitoring the progress of the experiments, management of day-to-day program activities, management of contractual agreements (if applicable), submission of all required technical reports, and maintenance of fiscal and programmatic systems to ensure accountability and performance tracking must be described. Applicants should describe how the Administrative Core Leads administrative, management, and leadership capabilities adequately provide for all activities listed above.
All other aspects of this NOFO remain the same.
Please direct all inquiries to:
Scientific/Research Contact:
Tam Nguyen, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone:
301-451-1203
Email: tam.nguyen@nih.gov